Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Can J Cardiol Retrieve available abstracts of 77 articles: HTML format

Single Articles

September 2025
1. CAI D, Sun T, Wei J, Deng L, et al
   Explainable Artificial Intelligence-Driven Risk Assessment for Malignant Ventricular Arrhythmia and Mortality in Acute Myocardial Infarction.
   Can J Cardiol. 2025 Sep 17:S0828-282X(25)01167.
   PubMed     Abstract available
   
   
   August 2025
2. WONG HJ, Low CE, Yau CE, Teo YH, et al
   Optimization of Guideline-Directed Medical Therapy Prescription after First-onset Myocardial Infarction in the Very Elderly.
   Can J Cardiol. 2025 Aug 22:S0828-282X(25)01035.
   PubMed    
   
   
   
3. SHI J
   Improving Guideline Therapy Assessment After First Myocardial Infarction in the Very Elderly Population.
   Can J Cardiol. 2025 Aug 11:S0828-282X(25)00659.
   PubMed    
   
   
   
4. HAYES SN, Gulati R
   Navigating Therapeutic Ambiguity: Thrombolysis in Spontaneous Coronary Artery Dissection Presenting As ST-Segment Elevation Myocardial Infarction.
   Can J Cardiol. 2025 Aug 4:S0828-282X(25)00648-8. doi: 10.1016/j.cjca.2025.
   PubMed    
   
   
   
5. SHENG Z, Che W, An S, Zhang Z, et al
   Assessing Coronary Microvascular Dysfunction Using Angiographic Frame Count in Patients With Angina and Nonobstructive Coronary Arteries.
   Can J Cardiol. 2025;41:1446-1455.
   PubMed     Abstract available
   
   
   
6. POLETTI E, Kearney KE, Chung CJ, Elison D, et al
   Predicting Mortality and Periprocedural Adverse Events in Patients Undergoing Complex and Higher Risk Percutaneous Coronary Intervention.
   Can J Cardiol. 2025;41:1434-1442.
   PubMed     Abstract available
   
   
   
7. ABDELGHANI M, Hemetsberger R, Hassan A, Abdelshafy M, et al
   Acute Coronary Syndromes after Transcatheter Aortic Valve Implantation: Incidence, Unique Mechanisms, and Outcomes.
   Can J Cardiol. 2025;41:1628-1637.
   PubMed     Abstract available
   
   
   
8. GUPTA AK, Mustafiz C, Mutahar D, Zaka A, et al
   Machine Learning vs Traditional Approaches to Predict All-Cause Mortality for Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
   Can J Cardiol. 2025;41:1564-1583.
   PubMed     Abstract available
   
   
   July 2025
9. ST JOHN PD, Bourgeois-Gosselin J, Tate RB
   Initial Presentation of Ischemic Heart Disease over the Life Course of Aging Men: The Manitoba Follow Up Study.
   Can J Cardiol. 2025 Jul 18:S0828-282X(25)00632.
   PubMed    
   
   
   
10. JAMHOUR-CHELH K, Jimenez-Kockar M, Fernandez-Peregrina E, Arzamendi D, et al
    Dissecting ST-elevation myocardial infarction pathophysiology through invasive physiology: Prognostic insight or actionable clinical guidance?
    Can J Cardiol. 2025 Jul 16:S0828-282X(25)00628.
    PubMed    
    
    
    
11. LI J, Xie P, Hu Y, Zhou Y, et al
    Predictive Value of Combining Angio-Based Index of Microcirculatory Resistance and Fractional Flow Reserve in Patients with STEMI.
    Can J Cardiol. 2025;41:1363-1371.
    PubMed     Abstract available
    
    
    June 2025
12. SKALIDIS I, Akodad M, Neylon A, Garot J, et al
    Angiography-Derived Microvascular Dysfunction Evaluation in Patients with Diabetes and ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 Jun 11:S0828-282X(25)00387.
    PubMed    
    
    
    
13. BOUDREAU R, Chih S, Le May M, Di Santo P, et al
    Balancing Costs and Benefits: A Less DanGerous Protocol for Myocardial Infarction Complicated by Cardiogenic Shock.
    Can J Cardiol. 2025 Jun 10:S0828-282X(25)00383.
    PubMed    
    
    
    May 2025
14. WU Y, Liu J, Du X, Li M, et al
    Prognostic Value of Angiography-derived Index of Microcirculatory Resistance in Patients with diabetes and ST-Segment Elevation Myocardial Infarction.
    Can J Cardiol. 2025 May 9:S0828-282X(25)00334-4. doi: 10.1016/j.cjca.2025.
    PubMed     Abstract available
    
    
    
15. UZUN F, Guner A, Serin E, Alizade E, et al
    Mini-crush or Nano-crush Stenting Technique for Complex Coronary Bifurcation Lesions: the Multicenter MINANO Registry.
    Can J Cardiol. 2025;41:878-887.
    PubMed     Abstract available
    
    
    
16. DERIMAY F, Mercier A, Aminian A, Maillard L, et al
    Benefit of Systematic "Jailed Wire" Technique for Bifurcation Provisional Stenting. A CABRIOLET Substudy.
    Can J Cardiol. 2025;41:871-877.
    PubMed     Abstract available
    
    
    April 2025
17. MATTIUZZI C, Lippi G
    Mortality Risk of Acute Myocardial Infarction and Acute Myocarditis in COVID-19 and Influenza: A U.S. Nationwide Analysis Using Death Certificates.
    Can J Cardiol. 2025 Apr 29:S0828-282X(25)00327.
    PubMed    
    
    
    
18. GIN K, Wong GC, Greene DN
    Advancing risk stratification with a troponin-based universal algorithm for non-ST elevation myocardial infarction: Are we ready for a C change?
    Can J Cardiol. 2025 Apr 4:S0828-282X(25)00242-9. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
19. SACCHI S, Venuti A, Gobbi FM, Gambaro A, et al
    Clinical Prediction Score for Successful Liberation from Temporary Mechanical Circulatory Support in Cardiogenic Shock Patients.
    Can J Cardiol. 2025;41:730-739.
    PubMed     Abstract available
    
    
    
20. SO DYF, Boudreau R, Chih S
    The Role of a Cardiogenic Shock Team in Decision Making Surrounding Mechanical Circulatory Support.
    Can J Cardiol. 2025;41:682-690.
    PubMed     Abstract available
    
    
    
21. HUNG A, Slawnych M, McGuinty C
    Enhancing Care in Cardiogenic Shock: Role of Palliative Care in Acute Cardiogenic Shock Through Destination Therapy.
    Can J Cardiol. 2025;41:669-681.
    PubMed     Abstract available
    
    
    
22. BARKER M, van Diepen S, Granger CB, Wong GC, et al
    Differences in Care and Outcomes in Cardiogenic Shock in Cardiac Intensive Care Units in the United States and Canada: CCCTN Registry Insights.
    Can J Cardiol. 2025;41:718-727.
    PubMed     Abstract available
    
    
    
23. BRAHMBHATT DH, Kalra S, Luk A, Billia F, et al
    From Escalate to Elevate: A New Paradigm for Comprehensive Cardiogenic Shock Management.
    Can J Cardiol. 2025;41:630-644.
    PubMed     Abstract available
    
    
    
24. CHILLETTI R, Ihle J, Butt W
    Mechanical Circulatory Support for Septic Shock in Children and Adults: Different But Similar.
    Can J Cardiol. 2025;41:605-612.
    PubMed     Abstract available
    
    
    
25. YUEN T, Senaratne JM
    Definition, Classification, and Management of Primary Noncardiac Causes of Cardiogenic Shock.
    Can J Cardiol. 2025;41:587-604.
    PubMed     Abstract available
    
    
    March 2025
26. MARZOLINI S, Oh P, Peterman JE, Wallace P, et al
    Sex Differences and Correlates of the Utility of the Cardiopulmonary Exercise Test for Prescribing Exercise at Entry to Cardiac Rehabilitation.
    Can J Cardiol. 2025;41:481-490.
    PubMed     Abstract available
    
    
    February 2025
27. THIESSEN N, Pickering JW, Kellner C, Haller PM, et al
    A common algorithm for cardiac troponin to rule-out and rule-in acute myocardial infarction.
    Can J Cardiol. 2025 Feb 26:S0828-282X(25)00173.
    PubMed     Abstract available
    
    
    
28. BOUDREAU R, Le May M, Malhotra N, Clifford C, et al
    Evaluating Volume and Resource Needs for Implementing an ST-Elevation Myocardial Infarction Shock Protocol.
    Can J Cardiol. 2025 Feb 6:S0828-282X(25)00107-2. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
29. WANG J, Wang P, Liu H, Zhao Y, et al
    Impact of High-Sensitivity Cardiac Troponin I Elevation After On- and Off-Pump Coronary Artery Bypass Grafting on Long-Term Prognosis.
    Can J Cardiol. 2025;41:294-305.
    PubMed     Abstract available
    
    
    January 2025
30. WONG HJ, Toh KZX, Low CE, Yau CE, et al
    Guideline-Directed Medical Therapy in Nonagenarians and Centenarians (>/=90 Years Old) After First-Onset Myocardial Infarction - A National Registry Study.
    Can J Cardiol. 2025 Jan 31:S0828-282X(25)00101.
    PubMed     Abstract available
    
    
    
31. RANDHAWA VK, Baran DA, Kanwar MK, Hernandez-Montfort JA, et al
    The comparative epidemiology, pathophysiology and management of cardiogenic shock associated with acute myocardial infarction and advanced heart failure.
    Can J Cardiol. 2025 Jan 30:S0828-282X(25)00097.
    PubMed     Abstract available
    
    
    
32. LUK A, Barker M, Billia P, Fordyce CB, et al
    ECLS-SHOCK and DanGer Shock: Implications for optimal temporary mechanical circulatory support use for cardiogenic shock due to acute myocardial infarction.
    Can J Cardiol. 2025 Jan 15:S0828-282X(25)00014.
    PubMed     Abstract available
    
    
    
33. CHEN H, Adam A, Oudit GY
    Apelin analog reduces the burden of post myocardial infarction adverse remodeling: a new therapeutic approach for ischemic heart disease.
    Can J Cardiol. 2025 Jan 7:S0828-282X(25)00003-0. doi: 10.1016/j.cjca.2025.
    PubMed    
    
    
    
34. LAVERDURE M, Clifford CR, Barry Q, Knoll W, et al
    Can the Present Canadian Health Care System Provide Evidence-Based Pharmaceutical Care? Consideration of Two Important Cardiovascular Clinical Contexts.
    Can J Cardiol. 2025;41:60-67.
    PubMed     Abstract available
    
    
    
35. ZENG M, Chu M, Xu L, Yi B, et al
    Value of Combined Optical Coherence Tomography and Optical Flow Ratio Measurements After Percutaneous Coronary Intervention.
    Can J Cardiol. 2025;41:1-8.
    PubMed     Abstract available
    
    
    December 2024
36. GIRAULT-SOTIAS PE, Deloux R, De Mota N, Riche S, et al
    The metabolically resistant apelin-17 analog LIT01-196 reduces cardiac dysfunction and remodeling in heart failure after myocardial infarction.
    Can J Cardiol. 2024 Dec 12:S0828-282X(24)01258.
    PubMed     Abstract available
    
    
    
37. MISTRY N, Mazer CD, Sivaswamy A, Haldenby O, et al
    Transfusion in Anemic Patients With Acute Coronary Syndromes: A Population-Based Cohort Study.
    Can J Cardiol. 2024;40:2515-2524.
    PubMed     Abstract available
    
    
    November 2024
38. LONN A, Niyonsenga T, Carroll SJ, Bauman A, et al
    Physical activity and sedentary behaviour thresholds for secondary prevention of coronary heart disease: morbidity survival tree analysis.
    Can J Cardiol. 2024 Nov 29:S0828-282X(24)01230.
    PubMed     Abstract available
    
    
    
39. HIASA Y, Higaki A, Kamei Y, Nishikawa T, et al
    Impact of Aromatase Inhibitors Treatment Duration on Coronary Artery Calcification in Postoperative Patients With Breast Cancer.
    Can J Cardiol. 2024;40:2224-2230.
    PubMed     Abstract available
    
    
    
40. TAN MC, Dinh D, Gayed D, Liang D, et al
    Associations Between Dual Antiplatelet Therapy Score and Long-Term Mortality After Percutaneous Coronary Intervention: Analysis of More Than 27,000 Patients.
    Can J Cardiol. 2024;40:2045-2053.
    PubMed     Abstract available
    
    
    
41. EIKELBOOM JW, Yi Q, McIntyre WF, Bosch J, et al
    Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches.
    Can J Cardiol. 2024;40:2171-2179.
    PubMed     Abstract available
    
    
    
42. NARUI S, Yamamoto MH, Mori H, Amemiya K, et al
    Mechanism of Stent Failure in Patients With Eruptive Calcified Nodule Treated With Rotational Atherectomy.
    Can J Cardiol. 2024;40:1998-2007.
    PubMed     Abstract available
    
    
    
43. SIBBALD M, Cioffi GM, Shenouda M, McGrath B, et al
    Intravascular Imaging in the Diagnosis and Management of Patients With Suspected Intracoronary Pathologies: A CJC White Paper.
    Can J Cardiol. 2024;40:1977-1994.
    PubMed     Abstract available
    
    
    
44. DOAN VD, Zheng C, Onwuzurike J, Chen A, et al
    Prognostic Value of Stress Myocardial Perfusion Imaging Across the Spectrum of Cardiovascular Risk.
    Can J Cardiol. 2024;40:2205-2214.
    PubMed     Abstract available
    
    
    
45. SHAVADIA JS, Okpalauwaekwe U, Kim M, Orvold J, et al
    Contemporary Outcomes of Acute Coronary Syndromes in Indigenous Compared With Non-Indigenous Patients: A Northern Saskatchewan Perspective.
    Can J Cardiol. 2024;40:2094-2101.
    PubMed     Abstract available
    
    
    October 2024
46. ZHAO C, Lu P, Wang J, Liu Y, et al
    A Novel Therapy for the Failing Right Ventricle in Acute Myocardial Infarction: The First Reported Cases.
    Can J Cardiol. 2024 Oct 29:S0828-282X(24)01040.
    PubMed     Abstract available
    
    
    September 2024
47. AZZALINI L
    A New Kid on the Block in the Rapidly Evolving Landscape of Intravascular Lithotripsy: Novel Technologies for Challenging Calcified Coronary Lesions.
    Can J Cardiol. 2024;40:1668-1670.
    PubMed    
    
    
    
48. WANG Q, Ma W, Zhang D, Zhang W, et al
    Effectiveness and Safety of a Novel Intravascular Lithotripsy System for Severe Coronary Calcification: The CALCI-CRACK Trial.
    Can J Cardiol. 2024;40:1657-1667.
    PubMed     Abstract available
    
    
    
49. AGUILAR M
    My Big Fat Coronary Bypass Surgery: Sex, Obesity, and Postoperative Atrial Fibrillation.
    Can J Cardiol. 2024;40:1576-1579.
    PubMed    
    
    
    
50. DZAVIK V
    A Left Main Bifurcation Risk Score: Can It Safely Guide Our Choice of Bifurcation Stenting Technique?
    Can J Cardiol. 2024;40:1632-1634.
    PubMed    
    
    
    
51. HE J, Cai Z, Wang HY, Zhang R, et al
    A New Scoring System Predicting Side-Branch Occlusion in Patients Undergoing Left Main Bifurcation Intervention: The LM V-RESOLVE Score.
    Can J Cardiol. 2024;40:1619-1631.
    PubMed     Abstract available
    
    
    August 2024
52. SMILOWITZ NR
    Unresolved Controversies in Revascularization for Cardiogenic Shock with Acute Myocardial Infarction.
    Can J Cardiol. 2024 Aug 30:S0828-282X(24)00934.
    PubMed    
    
    
    
53. MARQUIS-GRAVEL G, Bhatia S, Brown V, Goodman SG, et al
    Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention.
    Can J Cardiol. 2024;40.
    PubMed     Abstract available
    
    
    July 2024
54. ROSTON TM, Aghanya V, Savu A, Fordyce CB, et al
    Premature Acute Myocardial Infarction Treated with Invasive Revascularization: Comparing STEMI to NSTEMI in a Population-Based Study of Young Patients.
    Can J Cardiol. 2024 Jul 9:S0828-282X(24)00521-X. doi: 10.1016/j.cjca.2024.
    PubMed     Abstract available
    
    
    
55. RIVARD A
    Real-World Treatment of In-Stent Restenosis: The Return of the Balloon.
    Can J Cardiol. 2024;40:1258-1260.
    PubMed    
    
    
    
56. AZZALINI L, Johal GS
    Complex and High-Risk Percutaneous Coronary Intervention at Centers With No Surgical Back-Up: Are We Ready for Prime Time?
    Can J Cardiol. 2024;40:1247-1249.
    PubMed    
    
    
    
57. DOOLUB G, Ly HQ, Marquis-Gravel G
    Should Rotational Atherectomy Be Used More Often in STEMI to Treat Calcified Culprit Lesions?
    Can J Cardiol. 2024;40:1234-1236.
    PubMed    
    
    
    
58. AZZALINI L, Kearney KE, Lombardi WL
    Intravascular Lithotripsy-Facilitated Balloon-Assisted Subintimal Entry for Chronic Total Occlusion Percutaneous Coronary Intervention.
    Can J Cardiol. 2024;40:1261-1263.
    PubMed    
    
    
    
59. SHAMKHANI W, Rashid M, Moledina S, Ludman P, et al
    Complex High-Risk Percutaneous Coronary Intervention Types, Trends, and Outcomes in Nonsurgical Centres.
    Can J Cardiol. 2024;40:1237-1246.
    PubMed     Abstract available
    
    
    
60. KHEIFETS M, Rahat O, Bental T, Levi A, et al
    Outcomes of Drug-Eluting Balloons for In-Stent Restenosis: Large Cohort Analysis and Single-Center Clinical Experience.
    Can J Cardiol. 2024;40:1250-1257.
    PubMed     Abstract available
    
    
    June 2024
61. PACHECO C, Coutinho T, Bastiany A, Beanlands R, et al
    Canadian Cardiovascular Society/Canadian Women's Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA).
    Can J Cardiol. 2024;40:953-968.
    PubMed     Abstract available
    
    
    
62. MOHAMED MO, Ghosh AK, Banerjee A, Mamas M, et al
    Socioeconomic and Ethnic Disparities in the Process of Care and Outcomes Among Cancer Patients With Acute Coronary Syndrome.
    Can J Cardiol. 2024;40:1146-1153.
    PubMed     Abstract available
    
    
    
63. LUU JM, Bairey Merz CN, Wei J
    Reply to Pendyal-Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women's Ischemia Syndrome Evaluation (WISE) Cohort.
    Can J Cardiol. 2024;40:1177.
    PubMed    
    
    
    May 2024
64. LEE G, Malik A, Vervoort D, Tam DY, et al
    Revascularization in Left Ventricular Systolic Dysfunction: A Meta-Analysis of Kaplan-Meier Reconstructed Individual Patient Data.
    Can J Cardiol. 2024 May 30:S0828-282X(24)00414.
    PubMed     Abstract available
    
    
    April 2024
65. ROBERT YAO RJ, Fordyce CB
    Optimal transfusion threshold for anemic patients presenting with myocardial infarction and heart failure: dream or REALITY?
    Can J Cardiol. 2024 Apr 9:S0828-282X(24)00299-X. doi: 10.1016/j.cjca.2024.
    PubMed    
    
    
    
66. COURTNEY BK
    Very Late Stent Thrombosis in Japan: A Look Into the Future?
    Can J Cardiol. 2024;40:705-706.
    PubMed    
    
    
    
67. REA ABBAC, Mihajlovic V, Vishram-Nielsen JKK, Brahmbhatt DH, et al
    Pulmonary Artery Catheter Usage and Impact on Mortality in Patients With Cardiogenic Shock: Results From a Canadian Single-Centre Registry.
    Can J Cardiol. 2024;40:664-673.
    PubMed     Abstract available
    
    
    
68. MORI H, Sekimoto T, Arai T, Sakai R, et al
    Mechanisms of Very Late Stent Thrombosis in Japanese Patients as Assessed by Optical Coherence Tomography.
    Can J Cardiol. 2024;40:696-704.
    PubMed     Abstract available
    
    
    
69. DESSUREAULT A, Massie E, Fish D, Parent MC, et al
    Cardiomyopathy and Cardiogenic Shock Caused by Juvenile Hemochromatosis Improving With Guideline-Directed Medical Therapy Despite High Ferritin Levels.
    Can J Cardiol. 2024;40:662-663.
    PubMed    
    
    
    
70. AMJAD M
    High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery.
    Can J Cardiol. 2024;40:734.
    PubMed    
    
    
    
71. GUERRA PG, Simpson CS, Van Spall HGC, Asgar AW, et al
    Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive.
    Can J Cardiol. 2024;40:500-523.
    PubMed     Abstract available
    
    
    March 2024
72. AKIOYAMEN LE, Ko DT, Cram P, Landon BE, et al
    Approaches to comparing the impact of socioeconomic disadvantage on acute myocardial infarction care within and across countries: a Scoping review.
    Can J Cardiol. 2024 Mar 26:S0828-282X(24)00274.
    PubMed     Abstract available
    
    
    
73. SAADA M, Lavi S
    Angiography-Derived Index of Microvascular Resistance: A New Frontier in the Management of Patients With Coronary Artery Disease.
    Can J Cardiol. 2024;40:444-446.
    PubMed    
    
    
    
74. CHEN L, Sang C, Wu Y, Chen W, et al
    Coronary Angiography-Derived Index of Microcirculatory Resistance Associated With New-Onset Atrial Fibrillation in Patients With STEMI.
    Can J Cardiol. 2024;40:434-443.
    PubMed     Abstract available
    
    
    
75. SHOWKATHALI R, Yalamanchi RP, Kumar AM, Cs V, et al
    Isolated Giant Right Coronary Aneurysm Associated With IgG4-Related Disease.
    Can J Cardiol. 2024;40:447-449.
    PubMed    
    
    
    
76. TSUNETA S, Suno K, Fujieda Y, Watanabe M, et al
    Accumulation of Technetium-99m Tetrofosmin on Myocardial Perfusion Scintigraphy in a Patient With Immunoglobulin G4-Related Coronary Periarteritis.
    Can J Cardiol. 2024;40:450-451.
    PubMed    
    
    
    February 2024
77. DUCROCQ G, Cachanado M, Simon T, Puymirat E, et al
    Restrictive vs Liberal Blood Transfusions for Patients with Acute Myocardial Infarction and Anaemia by Heart Failure Status: An RCT Subgroup Analysis.
    Can J Cardiol. 2024 Feb 24:S0828-282X(24)00179.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.